Loading provider…
Loading provider…
Nephrology Physician in Providence, RI
NPI: 1063466282Primary Practice Location
Rhode Island Hospital
593 Eddy St, Providence, RI
Primary Employer
Mgmc, LLC
mgmcltd.co.uk
HQ Phone
Get MD Reginald's Phone Numberphone_androidMobile
Get MD Reginald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardRI State Medical License
DC State Medical License
2024 - 2026
RI State Medical License
1994 - 2024

American Board of Internal Medicine
Nephrology
Brown University
Masters • 2006
Until 2006
Beth Israel Deaconess Medical Center/Harvard Medical School
Fellowship • Transplant Nephrology
1995 - 1996
University of Toronto
B.S • Biological Sciences
Until 1985
Rhode Island Hospital/Brown University Health
Residency • Internal Medicine
1990 - 1993
Fellowship • Nephrology
1993 - 1995
Meharry Medical College School of Medicine
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 110 | 203 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 95 | 269 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 49 | 50 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 24 | 30 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 21 | 39 |
Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.
Authors: Miroslav Dostálek, Wai-Johnn Sam, Komal R. Paryani, Joyce S. Macwan, Reginald Y. Gohh, Fatemeh Akhlaghi
Publication Date: 2012-09
Authors: Simons, Malorie, Bautista, Josef, Occhiogrosso, Rachel, Scott-Sheldon, Lori Aj, Gohh, Reginald
Journal: Clin Nephrol
Lead Sponsor: Rhode Island Hospital
Collaborators: United Therapeutics, University of Rhode Island
Intervention / Treatment: DRUG: Treprostinil
Lead Sponsor: Genentech, Inc.
Collaborators: Amneal Pharmaceuticals, LLC, Lannett Company, Inc., Teva Pharmaceuticals USA, Endo Pharmaceuticals, Novartis Pharmaceuticals, Mylan Pharmaceuticals Inc, Accord Healthcare, Inc., Alkem Laboratories Ltd, Ascend Laboratories, LLC, Amta labs Limited, Apotex Corporation, Avet Lifesciences Limited, Biocon Pharma Limited, Concord Biotech Limited, Hetero Labs Limited, Unit-V, Hikma Pharmaceuticals USA Inc., Hisun Pharmaceuticals, Jubilant Cadista Pharmaceuticals, Inc., Liqmeds Worldwide Ltd, Meitheal Pharmaceuticals, Inc., Rising Pharma Holdings, Inc., RK Pharma Inc., Sandoz, Strides Pharma, Inc, TWi Pharmaceuticals, Inc., VistaPharm, Inc., Wuxi Fortune Pharmaceutical Co., Ltd, Zydus Pharmaceuticals
Lead Sponsor: Syneos Health
Collaborators: AbbVie, Alvogen Inc., Amneal Pharmaceuticals, LLC, Apotex Corp., Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Ltd., Dr. Reddy's Laboratories Limited, Gilead Sciences, Hetero Labs, Hikma Pharmaceuticals LLC, i3 Pharmaceuticals, LLC, Janssen Scientific Affairs, LLC, Lannett Company, Inc., Laurus Labs Limited, Lupin Pharmaceuticals, Inc., Macleods Pharmaceuticals Ltd, Merck Sharp & Dohme LLC, Mylan Laboratories, Pharmascience Inc., Qilu Pharmaceutical Co., Ltd., Sigmapharm Laboratories, Strides Pharma Science Limited, Teva Pharmaceuticals USA, ViiV Healthcare, Yung Shin Pharm. Ind. Co., Ltd., Zydus Pharmaceuticals USA, Inc.